COVID-19 BOOSTER VACCINE BASED ON SARS1 VIRUS

A COVID-19 booster vaccine based on the SARS1 virus. The COVID-19 booster vaccine is a vaccine against the SARS1 virus, and is a boost vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Animal experiment results show that an additional boost injection against the SARS1 vir...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HU, Yefan, CHU, Hin, HUANG, Jiandong, ZHANG, Baozhong
Format:	Patent
Sprache:	chi ; eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A COVID-19 booster vaccine based on the SARS1 virus. The COVID-19 booster vaccine is a vaccine against the SARS1 virus, and is a boost vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Animal experiment results show that an additional boost injection against the SARS1 virus is superior to vaccines against a variety of SARS-CoV-2 strains (including virus strain, Delta strain and Omicron strain), and has a better effect in neutralization titer and neutralization spectrum. Therefore, the vaccine against the SARS1 virus can be used as the boost vaccine against SARS-CoV-2. L'invention concerne un vaccin de rappel contre la COVID-19 basé sur le virus SARS1. Le vaccin de rappel contre la COVID-19 est un vaccin contre le virus SARS1, et est un vaccin de rappel contre le coronavirus du syndrome respiratoire aigu sévère 2 (SARS-CoV-2). Les résultats d'expérience sur animaux montrent qu'une injection de rappel supplémentaire contre le virus SARS1 est supérieure à des vaccins contre une variét